This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of TPVG either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Beyond Saving, Philip Mause, and Hidden Opportunities, all are supporting contributors for High Dividend Opportunities. Any recommendation posted in this article is not indefinite. We closely monitor all of our positions. We issue Buy and Sell alerts on our recommendations, which are exclusive to our members.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

This article was written by

Follow

Analyst’s Disclosure: I/we have no stock, option or similar derivative position in any of the companies mentioned, and no plans to initiate any such positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.

ZURICH — The much-anticipated 2026 Finalissima between Argentina and Spain has been officially cancelled, dashing hopes of a generational clash between Lionel Messi and teenage sensation Lamine Yamal.

UEFA announced the decision Sunday, March 15, 2026, citing the “current political situation in the region” that made it impossible to stage the match as planned in Qatar on March 27. The governing body expressed regret over the cancellation after failed attempts to relocate the game, thanking Real Madrid and Qatari authorities for their cooperation in exploring alternatives.

The Finalissima, pitting the winners of UEFA EURO 2024 (Spain) against CONMEBOL Copa América 2024 champions (Argentina), was set for Lusail Stadium in Doha — the same venue that hosted the 2022 World Cup final where Messi led Argentina to victory. The matchup promised fireworks: Messi, the 38-year-old icon still starring for Inter Miami and Argentina, against Yamal, the 18-year-old Barcelona winger who dazzled at EURO 2024 and has emerged as one of Europe’s brightest talents.

Fan excitement had built around the “Messi vs. Yamal” narrative, with social media buzzing over a potential first meeting between the veteran maestro and the young star often dubbed his heir apparent. The game would have tested Argentina’s veteran core against Spain’s dynamic, youthful squad under coach Luis de la Fuente.

The cancellation stems from escalating conflict in the Middle East, including U.S.-Israel strikes on Iran and regional instability that prompted Qatar to suspend domestic leagues and reconsider hosting international events. UEFA stated that despite “strong determination to save the important fixture,” relocation proved unfeasible at short notice.

Proposals included shifting the match to Real Madrid’s Santiago Bernabéu with a 50-50 fan split, but Argentina’s Football Association (AFA) rejected it, citing home advantage concerns for Spain. Other ideas — a two-legged tie in Madrid and Buenos Aires, or neutral European venues — also failed to gain acceptance. Argentina reportedly countered with post-World Cup scheduling or different sites, but Spain cited calendar constraints and no available dates.

UEFA emphasized that each alternative “ultimately proved unacceptable to the Argentinian Football Association.” The AFA has not issued a detailed public response, though sources indicate frustration over leaked Bernabéu proposals and perceived bias toward European interests.

The decision leaves both federations to arrange separate international friendlies in the March window. Argentina, fresh off Copa América success, may seek matches in the U.S. or elsewhere to maintain momentum ahead of World Cup qualifying. Spain, riding high from EURO triumph, could face other European sides or South American opponents.

The Finalissima’s fate highlights challenges in intercontinental scheduling amid geopolitical tensions. The event, revived in 2022 when Argentina thrashed Italy 3-0 at Wembley, aimed to bridge UEFA and CONMEBOL while providing a prestigious one-off trophy. The inaugural modern edition drew massive viewership, but logistical hurdles and external factors have plagued subsequent editions.

Messi’s participation would have been a highlight in what he has hinted could be a winding-down phase of his international career. At 38, he remains Argentina’s talisman, though injury and club demands have limited recent appearances. Yamal, meanwhile, has exploded onto the scene with Barcelona and Spain, scoring crucial goals and earning praise for maturity beyond his years.

Fans expressed disappointment online, with many lamenting the lost opportunity for Messi and Yamal to share the pitch. Some speculated a World Cup 2026 meeting remains possible if both nations advance deep in the tournament co-hosted by the U.S., Mexico and Canada — though Messi’s age makes his involvement uncertain.

UEFA and CONMEBOL expressed commitment to future collaborations but offered no timeline for reviving the Finalissima format. The cancellation marks a setback for international football’s efforts to create marquee cross-continental spectacles outside major tournaments.

As the dust settles, attention shifts to club commitments and national team preparations. Messi continues his MLS campaign with Inter Miami, while Yamal pushes Barcelona’s La Liga title bid. The scrapped Finalissima leaves an asterisk on what could have been a memorable chapter in both players’ legacies.

RIYADH, Saudi Arabia — Cristiano Ronaldo remains sidelined with a hamstring injury sustained late February, prompting Al Nassr to send the 41-year-old superstar to Madrid for specialized rehabilitation. As the 2026 FIFA World Cup approaches in June, the setback has sparked questions about his fitness, though medical timelines suggest he should return to action well before the tournament begins.

Ronaldo limped off in the 81st minute of Al Nassr’s 3-1 Saudi Pro League victory over Al Fayha on February 28, 2026. Initial assessments described the issue as muscular fatigue, but further tests revealed it was “more serious than expected,” according to Al Nassr coach Jorge Jesus. The club confirmed a right hamstring injury in an official statement, noting Ronaldo had begun a rehabilitation program with daily evaluations.

Jesus elaborated during a March 6 press conference that Ronaldo required rest and advanced treatment unavailable in Saudi Arabia. “After the tests he underwent, it became clear that it is a more serious injury than we were expecting,” Jesus said. “He will need rest and recovery. Cristiano will travel to Spain for treatment, as will other players who were injured.” Ronaldo has since been working with his personal physiotherapist in Madrid, incorporating methods like pressotherapy and high-tech recovery devices to accelerate healing.

Reports from Saudi outlet Al-Sharq Al-Awsat indicate Ronaldo is expected to return to Saudi Arabia by the end of March, positioning him for a potential comeback on April 3 against Al-Najma, the league’s bottom team. That timeline aligns with estimates of two to four weeks sidelined, depending on the injury’s grade. A mild grade-one strain typically heals in one to three weeks, while a grade-two partial tear could extend to four to eight weeks. Al Nassr has not classified the severity publicly, but the club emphasized day-by-day monitoring and Ronaldo’s determination to return quickly.

The injury has already caused Ronaldo to miss multiple matches, including league games against Neom SC and Al Khaleej, as well as any rescheduled fixtures. He has scored 21 goals in 22 Saudi Pro League appearances this season, underscoring his continued elite output despite his age. The setback follows a period of heavy workload — Ronaldo started 11 games in early 2026 — raising questions about managing his minutes as he prepares for what he has called his likely final major international tournament.

Ronaldo has repeatedly stated that the 2026 World Cup, co-hosted by the United States, Mexico and Canada, will probably be his last. Speaking in late 2025, he told CNN, “Definitely, yes, because I will be 41 years old.” He emphasized feeling “very good” physically, still sharp and capable of scoring, but acknowledged retirement looms within one or two years. At the World Cup, Ronaldo would become one of the oldest outfield players in tournament history if selected, aiming for a record sixth appearance and chasing his first World Cup title after near-misses in 2006, 2010, 2014, 2018 and 2022.

Portugal coach Roberto Martinez has yet to comment specifically on the injury’s impact on national team preparations, but the timing is delicate. Portugal has friendlies scheduled against Mexico and the United States in late March — key tune-ups for World Cup qualifying and final roster decisions. Some reports suggest Ronaldo risks missing those matches if recovery lags, though his targeted April return would allow ample time to regain match fitness before June’s tournament opener.

Experts remain optimistic about Ronaldo’s participation. His rigorous training regimen, access to top medical care and history of overcoming setbacks support a strong chance of featuring in North America. At 41, questions about speed and durability persist, but Ronaldo’s goal-scoring consistency — he remains Portugal’s all-time leading scorer — and leadership role make him a near-certainty for inclusion if fit. Former teammates and analysts note his mental drive often accelerates recovery.

The injury has also drawn attention to broader concerns for veteran players in high-stakes environments. Ronaldo’s move to Al Nassr in 2023 allowed him to maintain competitive minutes in a less physically demanding league compared to Europe, aiding longevity. Yet the current hamstring issue highlights the challenges of sustaining peak performance into the early 40s.

Fans and media continue monitoring updates from Madrid, where Ronaldo has shared occasional social media glimpses of his rehab without revealing specifics. Al Nassr and Portugal both prioritize his long-term health, balancing immediate club needs with World Cup ambitions.

As March progresses, the focus shifts to Ronaldo’s progress in Spain. A smooth recovery would see him back on the pitch by early April, positioning him ideally for Portugal’s World Cup campaign. While the injury introduces uncertainty, Ronaldo’s track record suggests he remains a formidable force capable of defying age once more on the global stage.

More than 150 people onboard a Princess Cruises ship became ill with norovirus during a Caribbean voyage this week, according to the Centers for Disease Control and Prevention (CDC).

The outbreak occurred aboard the Star Princess during a voyage from March 7 to March 14, according to the CDC’s Vessel Sanitation Program (VSP), which monitors illness on cruise ships.

Those reported sick included 104 passengers and 49 crew members — out of 4,307 passengers and 1,561 crew members in total, the CDC said.

The outbreak was reported to the VSP on March 11, less than a week after the voyage began.

BABY FOOD RECALLED NATIONWIDE AFTER DANGEROUS TOXIN FOUND IN FEDERAL TESTING RAISES HEALTH CONCERNS

A Princess Cruises vessel, pictured here, at sea.  (Princess Cruises / Fox News)

According to the CDC, the most commonly reported symptoms were diarrhea and vomiting, which are typical signs of norovirus infection.

In response to the outbreak, Princess Cruises increased cleaning and disinfection procedures, isolated sick passengers and crew members, and collected stool samples from ill individuals for testing, the CDC said.

GROUND STOP LIFTED AT MAJOR DC-AREA AIRPORTS AFTER CHEMICAL ODOR DISRUPTS AIR TRAFFIC CONTROL

Ship officials also consulted with CDC health officials about sanitation practices and reporting cases, according to the agency.

Closeup look of the Coral Princess at a port.  (Princess Cruises / Fox News)

The VSP is conducting an environmental assessment and outbreak investigation to help the ship control the spread of the illness.

The tracking site CruiseMapper showed the vessel docked in Fort Lauderdale on Saturday before continuing its voyage. Its itinerary indicated the ship was scheduled to visit Princess Cays in the Bahamas later Sunday.

Norovirus is a highly contagious virus that commonly causes vomiting and diarrhea and can spread quickly in close quarters such as cruise ships, according to health officials.

FILE: A view of the sign of Center for Disease Control headquarters is seen in Atlanta, on Aug. 6, 2022. (Nathan Posner/Anadolu Agency via Getty Images / Getty Images)

The CDC notes that illness totals reported during a cruise represent the cumulative number of cases across the entire voyage — not necessarily people who were sick at the same time.

CLICK HERE TO GET FOX BUSINESS ON THE GO

Cruise ships are required to report gastrointestinal illness cases to the CDC, which tracks outbreaks and works with cruise lines to implement sanitation and containment measures when they occur.

FOX Business has reached out to Princess Cruises and the CDC for further comment.

This article was written by

Follow

Analyst’s Disclosure: I/we have a beneficial long position in the shares of MPLX either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock is mentioned in this article.

Seeking Alpha’s Disclosure: Past performance is no guarantee of future results. No recommendation or advice is being given as to whether any investment is suitable for a particular investor. Any views or opinions expressed above may not reflect those of Seeking Alpha as a whole. Seeking Alpha is not a licensed securities dealer, broker or US investment adviser or investment bank. Our analysts are third party authors that include both professional investors and individual investors who may not be licensed or certified by any institute or regulatory body.